In December 2012, Merck & Co. reported that it was a named defendant in over 200 Propecia sexual dysfunction lawsuits which had been brought by 415 plaintiffs. The lawsuits represent a 32.5 percent rise over the previous quarter according to Merck’s third quarter earnings report. The third quarter report also confirmed that Propecia’s profitability was on the decline. The quarterly report indicates sales dropped about 7%, $104 million from $112 million for the same 2011 period.
Propecia is a medication manufactured by Merck & Co. used by men for the treatment of male baldness. Propecia contains finasteride, a drug initially used by Merck & Co. to treat symptomatic benign prostatic enlargement under the drug label Proscar. Testosterone is the main androgen in men and is needed for normal sperm, bone, and muscle development in addition to potency and libido. Dihydrotestosterone (DHT) has no physiological role in the adult male but is involved in producing prostate enlargement, balding, and body hair. Merck & Co. determined that DHT was a causative factor in male pattern baldness. The mechanism of Propecia is quite simple because it inhibits the production of testosterone, a male sex hormone, and thus decreases the problems of elevated testosterone or testosterone sensitivity while creating the same problems as if a man had low testosterone.
Sexual side effects associated with both Proscar and Propecia may be irreversible. Men whom have suffered sexual problems may have a claim against Merck & Co., the manufacturer of both Propecia and Proscar. Consulting an attorney knowledgeable about the Propecia litigation is critical in investigating a potential claim. Oracle Law Group is actively investigating Propecia and offers a free consultation to men evaluating a potential claim. Call today for a free consultation.